Evidence map›Paper›PMID 39307423›Full record

ArticleMolecular & cellular proteomics : MCP2024

Proteome-Scale Tissue Mapping Using Mass Spectrometry Based on Label-Free and Multiplexed Workflows.

Yumi Kwon, Jongmin Woo, Fengchao Yu, Sarah M Williams, Lye Meng Markillie, Ronald J Moore, Ernesto S Nakayasu, Jing Chen, Martha Campbell-Thompson, Clayton E Mathews and 3 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sex Differences in Lung Immunity.Immunological reviews · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Spatial Proteomics towards cellular Resolution.Expert review of proteomics · 2024
    Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yumi KwonEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, United States.
Jongmin WooEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, United States.
Fengchao YuDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, United States.
Sarah M WilliamsEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, United States.
Lye Meng MarkillieEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington, United States.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States.
Ernesto S NakayasuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States.
Jing ChenDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, United States.
Martha Campbell-ThompsonDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, United States.
Clayton E MathewsDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, United States.
Alexey I NesvizhskiiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, United States; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States.
Wei-Jun QianBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States. Electronic address: Weijun.Qian@pnnl.gov.
Ying ZhuDepartment of Proteomic and Genomic Technologies, Genentech Inc, South San Francisco, California, United States. Electronic address: zhu.ying@gene.com.

Funding

COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
Organ Specific ProjectU54DK127823 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI MATHEWS, CLAYTON E · 2020 to 2023
$5.1M
NIDDK NIH HHS U54 DK127823NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Multiplexed bimolecular profiling of tissue microenvironment, or spatial omics, can provide deep insight into cellular compositions and interactions in healthy and diseased tissues. Proteome-scale tissue mapping, which aims to unbiasedly visualize all the proteins in a whole tissue section or region of interest, has attracted significant interest because it holds great potential to directly reveal diagnostic biomarkers and therapeutic targets. While many approaches are available, however, proteome mapping still exhibits significant technical challenges in both protein coverage and analytical throughput. Since many of these existing challenges are associated with mass spectrometry-based protein identification and quantification, we performed a detailed benchmarking study of three protein quantification methods for spatial proteome mapping, including label-free, TMT-MS2, and TMT-MS3. Our study indicates label-free method provided the deepest coverages of ∼3500 proteins at a spatial resolution of 50 μm and the highest quantification dynamic range, while TMT-MS2 method holds great benefit in mapping throughput at >125 pixels per day. The evaluation also indicates both label-free and TMT-MS2 provides robust protein quantifications in identifying differentially abundant proteins and spatially covariable clusters. In the study of pancreatic islet microenvironment, we demonstrated deep proteome mapping not only enables the identification of protein markers specific to different cell types, but more importantly, it also reveals unknown or hidden protein patterns by spatial coexpression analysis.

Indexed as

ProteomeProteomicsAnimalsHumansIslets of LangerhansMass SpectrometryMiceWorkflowProteomeisobaric labelinglabel freenanoPOTSproteome mappingspatial proteomics

Identifiers

PMID39307423
PMCPMC11541776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.